HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In-Chul Park Selected Research

tubulosine

1/2020Tubulosine selectively inhibits JAK3 signalling by binding to the ATP-binding site of the kinase of JAK3.
9/2019Anticancer Activity of Tubulosine through Suppression of Interleukin-6-Induced Janus Kinase 2/Signal Transducer and Activation of Transcription 3 Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


In-Chul Park Research Topics

Disease

55Neoplasms (Cancer)
07/2022 - 07/2002
30Breast Neoplasms (Breast Cancer)
01/2022 - 02/2009
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 11/2006
16Lung Neoplasms (Lung Cancer)
04/2018 - 11/2006
8Glioblastoma (Glioblastoma Multiforme)
01/2022 - 07/2002
5Glioma (Gliomas)
12/2014 - 07/2002
5Carcinoma (Carcinomatosis)
03/2014 - 06/2009
5Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2008 - 07/2002
4Inflammation (Inflammations)
01/2022 - 02/2014
4Neoplasm Metastasis (Metastasis)
03/2021 - 07/2002
4Hypoxia (Hypoxemia)
03/2020 - 07/2007
4Carcinogenesis
07/2019 - 01/2010
3Hepatocellular Carcinoma (Hepatoma)
03/2021 - 01/2010
3Mitochondrial Diseases (Mitochondrial Disease)
01/2018 - 01/2007
3Brain Neoplasms (Brain Tumor)
02/2006 - 07/2002
2Fibrosarcoma
03/2006 - 08/2005
2Burkitt Lymphoma (Burkitt's Lymphoma)
09/2003 - 08/2003
1Type 2 Diabetes Mellitus (MODY)
07/2022
1Melanoma (Melanoma, Malignant)
04/2022
1Adenocarcinoma of Lung
01/2022
1Immune System Diseases (Immune Disorders)
01/2020
1Acidosis
01/2020

Drug/Important Bio-Agent (IBA)

11Arsenic Trioxide (Trisenox)FDA Link
02/2016 - 07/2002
10Proteins (Proteins, Gene)FDA Link
03/2021 - 09/2006
8Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 12/2004
7Pharmaceutical PreparationsIBA
07/2022 - 01/2006
6Phosphotransferases (Kinase)IBA
04/2018 - 07/2002
6Matrix Metalloproteinases (MMPs)IBA
12/2014 - 07/2002
6Sulindac (Copal)FDA LinkGeneric
07/2009 - 02/2005
5MicroRNAs (MicroRNA)IBA
12/2021 - 06/2009
5Hormones (Hormone)IBA
02/2020 - 03/2016
5ErbB Receptors (EGF Receptor)IBA
07/2019 - 09/2006
5Small Interfering RNA (siRNA)IBA
01/2018 - 12/2004
5SurvivinIBA
09/2015 - 11/2006
5Ribosomal Protein S6 Kinases (S6 Kinase)IBA
08/2015 - 03/2013
5p38 Mitogen-Activated Protein KinasesIBA
07/2009 - 07/2002
4TamoxifenFDA LinkGeneric
01/2022 - 08/2013
4Mechanistic Target of Rapamycin Complex 1IBA
12/2020 - 08/2013
4Biological ProductsIBA
01/2020 - 02/2006
4Biomarkers (Surrogate Marker)IBA
07/2019 - 01/2010
4VorinostatFDA Link
08/2011 - 03/2008
4CaspasesIBA
03/2008 - 08/2003
3Metformin (Glucophage)FDA LinkGeneric
07/2022 - 01/2016
3MelatoninIBA
01/2022 - 02/2016
3Estrogens (Estrogen)FDA Link
02/2020 - 04/2017
3Estrogen ReceptorsIBA
02/2020 - 08/2013
3EnzymesIBA
12/2019 - 06/2004
3piperlongumineIBA
01/2017 - 12/2014
3Messenger RNA (mRNA)IBA
09/2015 - 09/2006
3AntioxidantsIBA
07/2014 - 06/2004
2navitoclaxIBA
01/2022 - 08/2015
2Amino AcidsFDA Link
12/2021 - 03/2020
2Cisplatin (Platino)FDA LinkGeneric
07/2021 - 01/2006
2CateninsIBA
03/2021 - 02/2014
2Cysteine (L-Cysteine)FDA Link
03/2020 - 07/2014
2tubulosineIBA
01/2020 - 09/2019
2bafilomycin A1IBA
01/2018 - 08/2013
2Adenosine Triphosphatases (ATPase)IBA
01/2018 - 01/2016
2Caspase 3 (Caspase-3)IBA
01/2018 - 09/2003
2Radiation-Sensitizing AgentsIBA
01/2016 - 08/2011
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2014 - 06/2010
2Glucose (Dextrose)FDA LinkGeneric
10/2013 - 03/2013
2Histone Deacetylase InhibitorsIBA
08/2011 - 12/2009
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2010 - 09/2006
2Cytochromes c (Cytochrome c)IBA
03/2008 - 02/2006
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2007 - 09/2006
2Aligeron (AS 2)IBA
01/2007 - 12/2004
2Tissue Inhibitor of Metalloproteinase-1IBA
03/2006 - 07/2002
2DNA (Deoxyribonucleic Acid)IBA
03/2006 - 02/2006
2Penicillamine (Cuprimine)FDA Link
02/2006 - 05/2003
2NF-kappa B (NF-kB)IBA
08/2005 - 11/2004
2IonomycinIBA
09/2003 - 08/2003
1Phenformin (Fenformin)IBA
07/2022
1Therapeutic UsesIBA
07/2022
1daphnetinIBA
04/2022
1Melanocyte-Stimulating Hormones (MSH)IBA
04/2022
1AcriflavineIBA
01/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2022
1Mechanistic Target of Rapamycin Complex 2IBA
12/2021
1LuciferasesIBA
12/2021
1Trypan BlueFDA Link
12/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
07/2021
1Lysine (L-Lysine)FDA Link
12/2020
1LigandsIBA
03/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2020
1Selective Estrogen Receptor Modulators (SERM)IBA
02/2020
1Aromatase InhibitorsIBA
02/2020
1Lactate Dehydrogenase 5IBA
01/2020
1Janus Kinase 3IBA
01/2020
1phosphoserine aminotransferase (phosphoserine transaminase)IBA
12/2019
1Serine (L-Serine)FDA Link
12/2019
1Janus Kinase 2IBA
09/2019
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
09/2019
1InterleukinsIBA
09/2019
1Ribosomal Protein S6IBA
07/2019

Therapy/Procedure

19Therapeutics
01/2022 - 05/2003
5Radiotherapy
01/2020 - 12/2014
2Drug Therapy (Chemotherapy)
01/2018 - 09/2013
2Neoadjuvant Therapy
03/2016 - 09/2013
2Molecular Targeted Therapy
01/2016 - 01/2016